BioCentury
ARTICLE | Company News

Deltagen, Lilly protein deal

August 2, 2001 7:00 AM UTC

Genomics play DGEN and Eli Lilly (LLY) will evaluate, develop and market therapeutic secreted proteins. LLY will provide potential targets from its secreted protein pipeline for Deltagen to evaluate i...